Retinoids potentiate transforming growth factor-β activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-β receptors

Journal of Cellular Physiology

Volumn 176, Issue 3, 1998, Pages 565-573

  Yoshizawa, Misako ^a,b   Miyazaki, Hitoshi ^a   Kojima, Soichi ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b RIKEN TSUKUBA INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PLASMIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTOR SUBTYPE; RETINOIC ACID; RETINOID; RETINOL; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE;

ANIMAL CELL; AORTA; ARTICLE; BINDING AFFINITY; CATTLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBRINOLYSIS; NONHUMAN; PRIORITY JOURNAL;

ACTINS; ACTIVIN RECEPTORS, TYPE I; ANIMALS; ANTIGENS, CD31; AORTA; CATTLE; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FIBRINOLYTIC AGENTS; GENE EXPRESSION REGULATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RETINOIDS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

ANIMALIA; BOS TAURUS; BOVINAE; TRIXIS;

EID: 0031858069     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199809)176:3<565::AID-JCP13>3.0.CO;2-Z     Document Type: Article

References (56)

1. Bailly, S., Brand, C., Chambaz, E.M., and Feige, J.-J. (1997) Analysis of small latent transforming growth factor-β complex formation and dissociation by surface plasmon resonance: Absence of direct interaction with thrombospondins. J. Biol. Chem., 272:16329-16334.
2. Braunhut, S.J., and Palomares, M. (1991) Modulation of endothelial cell shape and growth by retinoids. Microvasc. Res., 41:47-62.
3. Chambon, P. (1996) A decade of molecular biology of retinoic acid receptors. FASEB J., 10:940-954.
4. Cheifetz, S., Bellón, T., Calés, C., Vera, S., Bernabeu, C., Massagué, J., and Letarte, M. (1992) Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J. Biol. Chem., 267:19027-19030.
5. Chomczynski, P., and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162:156-159.
6. Cohen, P.S., Letterio, J.J., Gaetano, C., Chan, J., Matsumoto, K., Sporn, M.B., and Thiele, C.J. (1995) Induction of transforming growth factor β1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuro-blastoma cell lines. Cancer Res., 55:2380-2386.
7. DeCoteau, J.F., Knaus, P.I., Yankelev, H., Reis, M.D., Lowsky, R., Lodish, H.F., and Kadin, M.E. (1997) Loss of functional cell surface transforming growth factor β (TGF-β) type 1 receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA, 94:5877-5881.
8. Dennis, P.A., and Rifkin, D.B. (1991) Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA, 88:580-584.
9. Derynck, R. (1994) Transforming growth factor-beta. In: The Cytokine Handbook, 2nd Ed. A.W. Thomson, ed., Academic Press, San Diego, pp. 319-342.
10. Fafeur, V., Terman, B.I., Blum, J., and Böhlen, P. (1990) Basic FGF treatment of endothelial cells down-regulates the 85-kDa TGFβ receptor subtype and decreases the growth inhibitory response to TGF-β1. Growth Factors, 3:237-245.
11. Falk, L.A., Benedetti, F.D., Lohrey, N., Birchenall-Roberts, M.C., Ellingsworth, L.W., Faltynek, C.R., and Ruscetti, F.W. (1991) Induction of transforming growth factor-β1 (TGF-β1) receptor expression and TGF-β1 protein production in retinoic acid-treated HL-60 cells: Possible TGF-β1-mediated autocrine inhibition. Blood, 77:1248-1255.
12. Flaumenhaft, R., Kojima, S., Abe, M., and Rifkin, D.B. (1993a) Activation of latent transforming growth factor β. In: Advances in Pharmacology 24. J.T. August, M.W. Anders, and F. Murad, eds., Academic Press, San Diego, pp. 51-76.
13. Flaumenhaft, R., Abe, M., Sato, Y., Miyazono, K., Harpel, J., Heldin, C.-H., and Rifkin, D.B. (1993b) Role of the latent TGF-β binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells. J. Cell Biol., 120:995-1002.
14. Friedman, S.L., Yamasaki, G., and Wong, L. (1994) Modulation of transforming growth factor β receptors of rat lipocytes during the hepatic wound healing response. J. Biol. Chem., 269:10551-10558.
15. Ge, A.Z., and Butcher, E.C. (1994) Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-β ligand. Gene, 138:201-206.
16. Glick, A.B., Flanders, K.C., Danielpour, D., Yuspa, S.H., and Sporn, M.B. (1989) Retinoic acid induces transforming growth factor-β2 in cultured keratinocytes and mouse epidermis. Cell Regul., 1:87-97.
17. Gudas, L.J., Sporn, M.B., and Roberts, A.B. (1994) Cellular Biology and Biochemistry of the Retinoids. In: The Retinoids: Biology, Chemistry, and Medicine, 2nd Ed. M.B. Sporn, A.B. Roberts, and D.S. Goodman, eds., Raven Press, New York, pp. 443-520.
18. Heldin, C.-H., Miyazono, K., and Dike, P.T. (1997) TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature, 390:465-471.
19. Huong, P.L.T., Kolk, A.H.J., Eggelte, T.A., Verstijnen, C.P.H.J., Gilis, H., and Hendriks, J.T. (1991) Measurement of antigen specific lymphocyte proliferation using 5-bromo-deoxyuridine incorporation. J. Immunol. Methods, 140:243-248.
20. Imai, S., Okuno, M., Moriwaki, H., Muto, Y., Murakami, K., Shudo, K., Suzuki, Y., and Kojima, S. (1997) 9,13-di-cis-Retinoic acid induces the production of tPA and activation of latent TGF-β via RARα in a human liver stellate cell line, LI90. FEBS Lett., 411:102-106.
21. Ingber, D., and Folkman, J. (1988) Inhibition of angiogenesis through modulation of collagen metabolism. Lab. Invest., 59:44-51.
22. Kojima, S., and Rifkin, D.B. (1993) Mechanism of retinoid-induced activation of latent transforming growth factor-β in bovine endothelial cells. J. Cell. Physiol., 155:323-332.
23. Kojima, S., Hagiwara, H., Shimonaka, M., Saito, Y., and Inada, Y. (1986) Synergism of retinoids and L-ascorbic acid in producing plasminogen activator in endothelial cells. Biomed. Res., 7:155-159.
24. Kojima, S., Harpel, P.C., and Rifkin, D.B. (1991) Lipoprotein (a) inhibits the generation of transforming growth factor β: An endogenous inhibitor of smooth muscle cell migration. J. Cell Biol., 113:1439-1445.
25. Kojima, S., Nara, K., and Rifkin, D.B. (1993) Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J. Cell Biol., 121:439-448.
26. Kojima, S., Muramatsu, H., Amanuma, H., and Muramatsu, T. (1995a) Midkine enhances fibrinolytic activity of bovine endothelial cells. J. Biol. Chem., 270:9590-9596.
27. Kojima, S., VerNooy, R., Moscatelli, D., Amanuma, H., and Rifkin, D.B. (1995b) Lipopolysaccharide inhibits activation of latent transforming growth factor-β in bovine endothelial cells. J. Cell. Physiol., 163:210-219.
28. Kojima, S., Inui, T., Muramatsu, H., Suzuki, Y., Kadomatsu, K., Yoshizawa, M., Hirose, S., Kimura, T., Sakakibara, S., and Muramatsu, T. (1997) Dimerization of midkine by tissue transglutaminase and its functional implication. J. Biol. Chem., 272:9410-9416.
29. Krätzschmar, J., Haendler, B., Kojima, S., Rifkin, D.B., and Schleuning, W.-D. (1993) Bovine urokinase-type plasminogen activator and its receptor: Cloning and induction by retinoic acid. Gene, 125:177-183.
30. Lazzereschi, D., Ranieri, A., Mincione, G., Taccogna, S., Nardi, F., and Colletta, G. (1997) Human malignant thyroid tumors displayed reduced levels of transforming growth factor β receptor type II messenger RNA and protein. Cancer Res., 57:2071-2076.
31. Lyons, R.M., Gentry, L.E., Purchio, A.F., and Moses, H.L. (1990) Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J. Cell Biol., 110:1361-1367.
32. Macías-Silva, M., Abdollah, S., Hoodless, P.A., Pirone, R., Attisano, L., and Wrana, J.L. (1996) MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell, 87:1215-1224.
33. Mangelsdorf, D.J., Umesono, K., and Evans, R.M. (1994) In: The Retinoids. Biology, Chemistry, and Medicine, 2nd Ed. M.B. Sporn, A. B. Roberts, and D.S. Goodman, eds., Raven Press, New York, pp. 319-350.
34. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R.S., Zborowska, E., Kinzler, K.W., Vogelstein, B., Brattain, M., and Willson, J.K.V. (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science, 268:1336-1338.
35. Miyazono, K., ten Dijke, P., Ichijo, H., and Heldin, C.-H. (1994) Receptors for transforming growth factor-β. In: Advances in Immunology 55. F.J. Dixon, ed., Academic Press. San Diego, pp. 181-220.
36. Nara, K., Nakanishi, K., Hagiwara, H., Wakita, K., Kojima, S., and Hirose, S. (1989) Retinol-induced morphological changes of cultured bovine endothelial cells are accompanied by a marked increase in transglutaminase. J. Biol. Chem., 264:19308-19312.
37. Nunes, I., Kojima, S., and Rifkin, D.B. (1996) Effects of endogenously activated transforming growth factor-β on growth and differentiation of retinoic acid-treated HL-60 cells. Cancer Res., 56:495-499.
38. Nunes, I., Gleizes, P.-E., Metz, C.N., and Rifkin, D.B. (1997) Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β. J. Cell Biol. 136:1151-1163.
39. Oikawa, T., Hirotani, K., Nakamura, O., Shudo, K., Hiragun, A., and Iwaguchi, T. (1989) A highly potent antiangiogenic activity of retinoids. Cancer Lett., 48:157-162.
40. Okuno, M., Moriwaki, H., Imai, S., Muto, Y., Kawada, N., Suzuki, Y., and Kojima, S. (1997) Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-β in liver stellate cells. Hepatology, 26:913-921.
41. Oreffo, R.O.C., Mundy, G.R., Seyedin, S.M., and Bonewald, L.F. (1989) Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. Biochem. Biophys. Res. Commun., 158:817-823.
42. Paige, K., Palomares, M., D'Amore, P.A., and Braunhut, S.J. (1991) Retinol-induced modification of the extracellular matrix of endothelial cells: Its role in growth control. In Vitro Cell. Dev. Biol., 27A:151-157.
43. Roberts, A.B., and Sporn, M.B. (1990) The transforming growth factor-βs In: Peptide Growth Factors and Their Receptors. M.B. Sporn and A.B. Roberts, eds., Springer-Verlag, Berlin, Vol. I, pp. 419-472.
44. Saksela, O., Moscatelli, D., and Rifkin, D.B. (1987) The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J. Cell Biol., 105:957-963.
45. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
46. Sankar, S., Mahooti-Brooks, N., Bensen, L., McCarthy, T.L., Centrella, M., and Madri, J.A. (1996) Modulation of transforming growth factor β receptor levels on microvascular endothelial cells during in vitro angiogenesis. J. Clin. Invest., 97:1436-1446.
47. Sato, Y., and Rifkin, D.B. (1989) Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-β1-like molecule by plasmin during coculture. J. Cell Biol., 109:309-315.
48. Sato, Y., Tsuboi, R., Lyons, R., Moses, H., and Rifkin, D.B. (1990) Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: A self-regulating system. J. Cell Biol., 111:757-763.
49. Scatchard, G. (1949) The attractions of proteins for small molecules and ions. Ann. NY. Acad. Sci., 51:660-672.
50. Schultz-Cherry, S., Chen, H., Mosher, D.F., Misenheimer, T.M., Krutzsch, H.C., Roberts, D.D., and Murphy-Ullrich, J.E. (1995) Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1. J. Biol. Chem., 270:7304-7310.
51. Taketazu, F., Kato, M., Gobl, A., Ichijo, H., ten Dijke, P., Itoh, J., Kyogoku, M., Rönnelid, J., Miyazono, K., Heldin, C.-H., and Funa, K. (1994) Enhanced expression of transforming growth factor-βs and transforming growth factor-β type II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab. Invest. 70:620-630.
52. Tallman, M.S., Andersen, J.W., Schiffer, C.A., Appelbaum, F.R., Feusner, J.H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C.D., Rowe, J.M., and Wiernik, P.H. (1997) All-trans-retinoic acid in acute promyelocytic leukemia. N. Engl. J. Med., 337:1021-1028.
53. Turley, J.M., Falk, L.A., Ruscetti, F.W., Kasper, J.J., Francomano, T., Fu, T., Bang, O.-S., and Birchenall-Roberts, M.C. (1996) Transforming growth factor β1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms. Cell Growth Diff., 7:1535-1544.
54. Wieser, R., Wrana, J.L., and Massagué, J. (1995) GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J., 14:2199-2208.
55. Wrana, J.L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. (1994) Mechanism of activation of the TGF-β receptor. Nature, 370:341-347.
56. Yamashita, H., Ichijo, H., Grimsby, S., Morén, A., ten Dijke, P., and Miyazono, K. (1994) Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β. J. Biol. Chem., 269:1995-2001.